tiprankstipranks
Together Pharma Ltd. (IL:TGTR)
TASE:TGTR
Israel Market
TGTR
Together
RESEARCH TOOLSreports
Want to see IL:TGTR full AI Analyst Report?

Together (TGTR) Ratios

0 Followers

Together Ratios

IL:TGTR's free cash flow for Q2 2025 was ₪0.30. For the 2025 fiscal year, IL:TGTR's free cash flow was decreased by ₪ and operating cash flow was ₪0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.11 1.32 1.07 1.46 1.25
Quick Ratio
 0.43 0.43 0.36 0.35 0.31
Cash Ratio
 0.12 0.17 0.11 0.07 0.11
Solvency Ratio
 0.02 0.09 0.04 <0.01 -0.22
Operating Cash Flow Ratio
 0.13 0.09 0.04 0.30 -0.29
Short-Term Operating Cash Flow Coverage
 0.30 0.19 0.07 0.88 -0.63
Net Current Asset Value
₪ -13.29M₪ -9.83M₪ -24.34M₪ -68.36M₪ -67.46M
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.39 0.43 0.40 0.46
Debt-to-Equity Ratio
 1.07 1.24 1.91 -7.03 -141.03
Debt-to-Capital Ratio
 0.52 0.55 0.66 1.17 1.01
Long-Term Debt-to-Capital Ratio
 0.07 0.24 0.23 1.44 1.02
Financial Leverage Ratio
 3.24 3.21 4.41 -17.78 -304.68
Debt Service Coverage Ratio
 0.22 0.51 0.18 0.65 -0.35
Interest Coverage Ratio
 0.73 1.80 0.31 1.13 -0.37
Debt to Market Cap
 0.81 0.93 1.06 1.16 2.31
Interest Debt Per Share
 3.98 4.40 5.95 8.47 9.61
Net Debt to EBITDA
 4.09 1.86 6.17 1.85 -3.81
Profitability Margins
Gross Profit Margin
20.77%31.02%18.23%38.04%-18.85%
EBIT Margin
5.73%16.18%3.41%24.28%-63.31%
EBITDA Margin
11.40%23.25%9.30%30.35%-46.01%
Operating Profit Margin
5.73%16.18%3.41%24.28%-20.11%
Pretax Profit Margin
-2.36%4.45%-2.30%1.69%-116.33%
Net Profit Margin
-3.23%1.74%-1.22%-4.74%-107.35%
Continuous Operations Profit Margin
-3.17%1.75%-1.69%-2.78%-113.61%
Net Income Per EBT
137.13%39.24%52.96%-280.44%92.29%
EBT Per EBIT
-41.17%27.47%-67.63%6.97%578.35%
Return on Assets (ROA)
-1.84%1.24%-0.80%-3.12%-25.83%
Return on Equity (ROE)
-6.61%3.98%-3.52%55.38%7869.48%
Return on Capital Employed (ROCE)
6.92%21.45%4.80%24.91%-7.62%
Return on Invested Capital (ROIC)
4.62%5.99%2.16%-33.96%-5.81%
Return on Tangible Assets
-2.22%1.39%-0.96%-3.91%-34.14%
Earnings Yield
-7.31%3.61%-2.42%-11.80%-162.64%
Efficiency Ratios
Receivables Turnover
 3.73 6.34 5.66 7.21 3.74
Payables Turnover
 2.55 4.22 3.68 4.10 3.97
Inventory Turnover
 1.26 1.20 1.39 1.02 0.83
Fixed Asset Turnover
 2.50 3.32 2.71 2.57 0.85
Asset Turnover
 0.57 0.71 0.65 0.66 0.24
Working Capital Turnover Ratio
 10.03 7.72 6.72 5.22 1.89
Cash Conversion Cycle
 244.66 276.21 227.30 319.28 444.10
Days of Sales Outstanding
 97.81 57.55 64.54 50.64 97.59
Days of Inventory Outstanding
 289.85 305.24 262.01 357.73 438.51
Days of Payables Outstanding
 143.00 86.58 99.25 89.09 92.00
Operating Cycle
 387.66 362.79 326.55 408.37 536.09
Cash Flow Ratios
Operating Cash Flow Per Share
 0.72 0.42 0.23 1.69 -1.71
Free Cash Flow Per Share
 0.70 0.33 0.11 1.59 -1.75
CapEx Per Share
 0.02 0.09 0.12 0.10 0.04
Free Cash Flow to Operating Cash Flow
 0.97 0.79 0.48 0.94 1.02
Dividend Paid and CapEx Coverage Ratio
 36.27 4.65 1.93 17.13 -41.24
Capital Expenditure Coverage Ratio
 36.27 4.65 1.93 17.13 -41.24
Operating Cash Flow Coverage Ratio
 0.20 0.11 0.04 0.27 -0.23
Operating Cash Flow to Sales Ratio
 0.12 0.06 0.03 0.16 -0.44
Free Cash Flow Yield
21.34%9.76%2.83%38.16%-68.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -13.67 27.69 -41.36 -8.48 -0.61
Price-to-Sales (P/S) Ratio
 0.54 0.48 0.50 0.40 0.66
Price-to-Book (P/B) Ratio
 0.82 1.10 1.45 -4.70 -48.38
Price-to-Free Cash Flow (P/FCF) Ratio
 4.69 10.25 35.28 2.62 -1.47
Price-to-Operating Cash Flow Ratio
 3.74 8.05 17.01 2.47 -1.50
Price-to-Earnings Growth (PEG) Ratio
 -0.23 -0.12 0.51 0.10 >-0.01
Price-to-Fair Value
 0.82 1.10 1.45 -4.70 -48.38
Enterprise Value Multiple
 8.82 3.94 11.60 3.18 -5.25
Enterprise Value
 86.83M 100.47M 103.59M 87.80M 75.39M
EV to EBITDA
 8.82 3.94 11.60 3.18 -5.25
EV to Sales
 1.01 0.92 1.08 0.96 2.41
EV to Free Cash Flow
 8.75 19.45 75.39 6.29 -5.36
EV to Operating Cash Flow
 8.51 15.27 36.36 5.92 -5.49
Tangible Book Value Per Share
 1.66 2.15 1.09 -3.50 -3.56
Shareholders’ Equity Per Share
 3.28 3.04 2.68 -0.89 -0.05
Tax and Other Ratios
Effective Tax Rate
 -0.34 0.61 0.27 2.65 0.02
Revenue Per Share
 6.07 6.93 7.73 10.36 3.89
Net Income Per Share
 -0.20 0.12 -0.09 -0.49 -4.18
Tax Burden
 1.37 0.39 0.53 -2.80 0.92
Interest Burden
 -0.41 0.27 -0.68 0.07 1.84
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.15 0.15 0.15 0.08 0.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -3.65 3.44 -2.43 -3.44 0.41
Currency in ILS